Systematic Review February 21, 2023

Substance Withdrawal–Associated Takotsubo Cardiomyopathy: A Review of the Literature

; ; ;

Prim Care Companion CNS Disord 2023;25(1):22r03304

ABSTRACT

Objective: To better understand Takotsubo cardiomyopathy, a rare but life-threatening complication of acute substance withdrawal.

Data Sources: A PubMed search was conducted to identify relevant case reports through 2021 using the medical subject headings alcohol withdrawal, opioid withdrawal, benzodiazepine withdrawal OR withdrawal AND Takotsubo OR stress cardiomyopathy.

Study Selection: Case reports were included in the review if there was a diagnosis of Takotsubo cardiomyopathy in the setting of withdrawal from substances of abuse. Case reports were excluded if patients were withdrawing from other substances, actively intoxicated, or had myocardial ischemia.

Data Extraction and Synthesis: Data were manually abstracted for the variables of interest, including demographics, symptoms, medical evaluation, and treatment. Descriptive statistics of the demographics, symptoms, medical evaluation, and treatment of Takotsubo cardiomyopathy were analyzed.

Results: The mean (SD) age of patients experiencing withdrawal-associated Takotsubo cardiomyopathy was 50.8 years (15.2), and 64% of patients were female. The most common signs and symptoms were tachycardia (60%), changes in blood pressure (48%), altered mental status (48%), dyspnea (32%), nausea or vomiting (28%), and chest pain (28%). All patients with a reported electrocardiogram (92%) demonstrated ECG abnormalities; 76% had an elevated troponin level, and 24% had an elevated CK-MB level. Medications that could treat withdrawal and α2-agonists were utilized for 60% and 12% of patients, respectively. Ventilator support, cardiopulmonary resuscitation, and intra-aortic balloon pump were needed for 24%, 8%, and 8%, respectively, of patients with withdrawal-associated Takotsubo cardiomyopathy.

Conclusions: Withdrawal-associated Takotsubo cardiomyopathy is a rare but potentially life-threatening complication of substance withdrawal. Clinicians should maintain a high degree of clinical suspicion for withdrawal-associated Takotsubo in patients with a history of substance use disorders or physical dependence on benzodiazepines or opioids, as the clinical presentation may be atypical.

  1. Hedden SL. Behavioral Health Trends in the United States: Results From the 2014 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Department of Health and Human Services.  Accessed January 10, 2023. https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf
  2. Centers for Disease Control and Prevention. Drug overdose deaths in the US Top 100,000 annually. Accessed January 10, 2023. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm
  3. O’Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998;338(9):592–602. PubMed CrossRef
  4. McNeely J, Gourevitch MN, Paone D, et al. Estimating the prevalence of illicit opioid use in New York City using multiple data sources. BMC Public Health. 2012;12(1):443. PubMed CrossRef
  5. Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348(18):1786–1795. PubMed CrossRef
  6. Suzuki K, Osada N, Akasi YJ, et al. An atypical case of “Takotsubo cardiomyopathy” during alcohol withdrawal: abnormality in the transient left ventricular wall motion and a remarkable elevation in the ST segment. Intern Med. 2004;43(4):300–305. PubMed CrossRef
  7. Maruyama S, Nomura Y, Fukushige T, et al. Suspected takotsubo cardiomyopathy caused by withdrawal of bupirenorphine in a child. Circ J. 2006;70(4):509–511. PubMed CrossRef
  8. Mitchell SA, Crone RA. Takotsubo cardiomyopathy: a case report. J Am Soc Echocardiogr. 2006;19(9):1190.e9–1190.e10. PubMed CrossRef
  9. Rivera JM, Locketz AJ, Fritz KD, et al. “Broken heart syndrome” after separation (from OxyContin). Mayo Clin Proc. 2006;81(6):825–828. PubMed CrossRef
  10. Kalra N, Khetpal P, Sorrell VL. Seriously stressed. Am J Med. 2009;122(8):735–737. PubMed CrossRef
  11. Yousuf MA, Adjei S, Kinder B. A 58-year-old woman with ST-segment elevation, seizures, and altered mental status in the setting of opiate withdrawal. Chest. 2009;135(4):1098–1101. PubMed CrossRef
  12. Lemesle F, Lemesle F, Nicola W, et al. First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction. Am J Emerg Med. 2010;28(3):387.e5–387.e6. PubMed CrossRef
  13. Alexandre J, Benouda L, Champ-Rigot L, et al. Takotsubo cardiomyopathy triggered by alcohol withdrawal. Drug Alcohol Rev. 2011;30(4):434–437. PubMed CrossRef
  14. Stöllberger C, Wegner C, Finsterer J. Seizure-induced Takotsubo syndrome is more frequent than reported. Int J Cardiol. 2011;150(3):359–360. PubMed CrossRef
  15. Thompson AG, Hung J. Takotsubo cardiomyopathy associated with alcohol withdrawal. Med J Aust. 2011;194(7):373. PubMed CrossRef
  16. Stout BJ, Hoshide R, Vincent DS. Takotsubo cardiomyopathy in the setting of acute alcohol withdrawal. Hawaii J Med Public Health. 2012;71(7):193–194. PubMed
  17. Chan JCM, Wong RSM, Chan TYK. Takotsubo cardiomyopathy associated with sudden benzodiazepine withdrawal. Clin Toxicol. 2012;50(4):323.
  18. Omar HR, Abdelmalak HD, Komorova I, et al. Alcohol withdrawal-induced Takotsubo. Intern Emerg Med. 2012;7(suppl 2):S107–S108. PubMed CrossRef
  19. Yazdan-Ashoori P, Nichols R, Baranchuk A. Takotsubo cardiomyopathy precipitated by alcohol withdrawal. Cardiol J. 2012;19(1):81–85. PubMed CrossRef
  20. Saiful FB, Lafferty J, Jun CH, et al. Takotsubo cardiomyopathy due to iatrogenic methadone withdrawal. Rev Cardiovasc Med. 2011;12(3):164–167. PubMed CrossRef
  21. Moore PK, Marzec LN, Krantz MJ. Signs of stress: deep symmetric T-wave inversions. Am J Med. 2013;126(8):682–684. PubMed CrossRef
  22. Revelo AE, Pallavi R, Espana-Schmidt C, et al. ‘Stoned’ people can get stunned myocardium: a case of heroin withdrawal precipitating Tako-Tsubo cardiomyopathy. Int J Cardiol. 2013;168(3):e96–e98. PubMed CrossRef
  23. Spadotto V, Zorzi A, Elmaghawry M, et al. Heart failure due to ‘stress cardiomyopathy’: a severe manifestation of the opioid withdrawal syndrome. Eur Heart J Acute Cardiovasc Care. 2013;2(1):84–87. PubMed CrossRef
  24. Sarcon A, Ghadri JR, Wong G, et al. Takotsubo cardiomyopathy associated with opiate withdrawal. QJM. 2014;107(4):301–302. PubMed CrossRef
  25. Agu CC, Bakhit A, Basunia M, et al. Takotsubo cardiomyopathy precipitated by delirium tremens. J Community Hosp Intern Med Perspect. 2015;5(6):29704. PubMed CrossRef
  26. Harris ZM, Alonso A, Kennedy TP. Adrenergic inhibition with dexmedetomidine to treat stress cardiomyopathy during alcohol withdrawal: a case report and literature review. Case Rep Crit Care. 2016;2016:9693653. PubMed CrossRef
  27. Olson PC, Agarwal V, Lafferty JC, et al. Takotsubo cardiomyopathy precipitated by opiate withdrawal. Heart Lung. 2018;47(1):73–75. PubMed CrossRef
  28. Surmaitis RM, Khalid MM, Vearrier D, et al. Takotsubo cardiomyopathy associated with buprenorphine precipitated withdrawal. Clin Toxicol (Phila). 2018;56(9):863–864. PubMed CrossRef
  29. Kulkarni M, Kulkarni A, Healy J, et al. Acute alcohol withdrawal-induced Takotsubo cardiomyopathy: a rare presentation. Chest. 2019;156(4):A2190–A2191. CrossRef
  30. Makani A, Genuardi M, Sciortino C, et al. Opioid withdrawal induced stress cardiomyopathy with recurrent cardiogenic shock. J Am Coll Cardiol. 2019;73(9 suppl 1):2207. CrossRef
  31. Sato H. Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. Clin Asp Myocard Inj from ischemia to Hear Fail. 1990:56–64.
  32. Brandspiegel HZ, Marinchak RA, Rials SJ, et al. A broken heart. Circulation. 1998;98(13):1349. PubMed CrossRef
  33. Deniz S, Bakal Ö, İnangil G, et al. Takotsubo cardiomyopathy occurring in the postoperative period. Turk J Anaesthesiol Reanim. 2015;43(1):47–49. PubMed CrossRef
  34. Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30(4):780–786. PubMed CrossRef
  35. Lee VH, Connolly HM, Fulgham JR, et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg. 2006;105(2):264–270. PubMed CrossRef
  36. Mugnai G, Pasqualin G, Prati D, et al. Recurrent multiform Takotsubo cardiomyopathy in a patient with epilepsy: broken heart or brain? Int J Cardiol. 2015;201:332–335. PubMed CrossRef
  37. Vergez M, Pirracchio R, Mateo J, et al. Tako Tsubo cardiomyopathy in a patient with multiple trauma. Resuscitation. 2009;80(9):1074–1077. PubMed CrossRef
  38. Eliades M, El-Maouche D, Choudhary C, et al. Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature. Thyroid. 2014;24(2):383–389. PubMed CrossRef
  39. Seno H, Komasawa N, Hasegawa Y, et al. Development of Takotsubo cardiomyopathy during recovery from general anesthesia: a case report. Masui. 2015;64(8):826–829. PubMed
  40. Law C, Khaliq A, Guglin M. Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo? Am J Emerg Med. 2013;31(11):1621.e1–1621.e3. PubMed CrossRef
  41. Goel S, Sharma A, Garg A, et al. Chemotherapy induced Takotsubo cardiomyopathy. World J Clin Cases. 2014;2(10):565–568. PubMed CrossRef
  42. Wittstein IS, Thiemann DR, Lima JAC, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548. PubMed CrossRef
  43. Naegele M, Flammer AJ, Enseleit F, et al. Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. Int J Cardiol. 2016;224:226–230. PubMed CrossRef
  44. Borg S, Czarnecka A, Kvande H, et al. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcohol Clin Exp Res. 1983;7(4):411–415. PubMed CrossRef
  45. Bell J, Bickford-Wimer PC, de la Garza R, et al. Increased central noradrenergic activity during benzodiazepine withdrawal: an electrophysiological study. Neuropharmacology. 1988;27(11):1187–1190. PubMed CrossRef
  46. McDonald T, Hoffman WE, Berkowitz R, et al. Heart rate variability and plasma catecholamines in patients during opioid detoxification. J Neurosurg Anesthesiol. 1999;11(3):195–199. PubMed CrossRef
  47. Pelliccia F, Kaski JC, Crea F, et al. Pathophysiology of Takotsubo syndrome. Circulation. 2017;135(24):2426–2441. PubMed CrossRef
  48. Singh K, Carson K, Shah R, et al. Meta-analysis of clinical correlates of acute mortality in takotsubo cardiomyopathy. Am J Cardiol. 2014;113(8):1420–1428. PubMed CrossRef
  49. Redfors B, Vedad R, Angerås O, et al. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction: a report from the SWEDEHEART registry. Int J Cardiol. 2015;185:282–289. PubMed CrossRef
  50. Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929–938. PubMed CrossRef
  51. Kyuma M, Tsuchihashi K, Shinshi Y, et al. Effect of intravenous propranolol on left ventricular apical ballooning without coronary artery stenosis (ampulla cardiomyopathy): three cases. Circ J. 2002;66(12):1181–1184. PubMed CrossRef